Mutations in modified virus Ankara protein 183 render it a non-functional counterpart of B14, an inhibitor of nuclear

Laura E McCoy1, Aodhnait S Fahy, Ron A-J Chen

  • 1Department of Virology, Imperial College London, London W2 1PG, UK.

Insights

Modified Vaccinia Ankara (MVA) protein 183 is unstable and does not inhibit NF-kappaB activation, unlike its Vaccinia virus counterpart B14. This suggests MVA

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Background:

  • Vaccinia virus (VACV) utilizes proteins like B14 to counteract host innate immunity by inhibiting nuclear factor kappaB (NF-kappaB) activation.
  • Modified Vaccinia Ankara (MVA), an attenuated VACV strain, is a promising vaccine vector, but its immunogenicity may be enhanced by modifying its proteins.

Purpose of the Study:

  • To characterize MVA protein 183, the counterpart of VACV B14, and assess its function in modulating host immune responses.
  • To determine if protein 183 can inhibit NF-kappaB activation and restore virulence in VACV.

Main Methods:

  • Protein stability assays in eukaryotic cells.
  • Assessment of NF-kappaB activation in response to cytokine stimulation.
  • Virulence restoration assays in VACV strains lacking the B14R gene.

Main Results:

  • MVA protein 183 exhibited instability in eukaryotic cells, requiring proteasome inhibition for stability.
  • Protein 183 failed to inhibit NF-kappaB activation.
  • Protein 183 did not restore virulence to VACV lacking the B14R gene.
  • A 6 amino acid deletion in alpha-helix 6 of protein 183 likely explains its instability and lack of function.

Conclusions:

  • MVA protein 183 is functionally distinct from VACV B14 due to instability and inability to inhibit NF-kappaB.
  • The structural difference, specifically the deletion in alpha-helix 6, underlies the functional deficiency of MVA protein 183.
  • These findings provide insights into MVA's immunomodulatory mechanisms and potential for vaccine vector development.

Related Concept Videos

Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.